These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38030143)

  • 1. A Superlong-Acting Growth Hormone-Polypeptide Fusion for Growth Hormone Deficiency Treatment.
    Yang Z; Yao Q; Gong L; Zhang F; Sun J; Sun Y; Gao W
    Adv Healthc Mater; 2024 Feb; 13(5):e2302507. PubMed ID: 38030143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, Pharmacodynamics, and Efficacy of a Novel Long-Acting Human Growth Hormone: Fc Fusion Protein.
    Kim SJ; Kwak HH; Cho SY; Sohn YB; Park SW; Huh R; Kim J; Ko AR; Jin DK
    Mol Pharm; 2015 Oct; 12(10):3759-65. PubMed ID: 26370910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
    Hou L; Chen ZH; Liu D; Cheng YG; Luo XP
    Drug Des Devel Ther; 2016; 10():13-21. PubMed ID: 26719670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel long-acting human growth hormone fusion protein (VRS-317): enhanced in vivo potency and half-life.
    Cleland JL; Geething NC; Moore JA; Rogers BC; Spink BJ; Wang CW; Alters SE; Stemmer WP; Schellenberger V
    J Pharm Sci; 2012 Aug; 101(8):2744-54. PubMed ID: 22678811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency.
    Du H; Wu D; Yi P; Bai X; Luo Y; Yang H; Chen S; Pan H; Zhu H
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):511-517. PubMed ID: 35245011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a sustained-release recombinant human growth hormone formulation.
    Kwak HH; Shim WS; Choi MK; Son MK; Kim YJ; Yang HC; Kim TH; Lee GI; Kim BM; Kang SH; Shim CK
    J Control Release; 2009 Jul; 137(2):160-5. PubMed ID: 19332090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin.
    Lanzi R; Tannenbaum GS
    Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic/pharmacodynamic model for recombinant human growth hormone effects on induction of insulin-like growth factor I in monkeys.
    Sun YN; Lee HJ; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1523-32. PubMed ID: 10336548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.
    Liang Y; Zhang C; Wei H; Du H; Zhang G; Yang Y; Zhang H; Gong H; Li P; Song F; Xu Z; He R; Zhou W; Zheng H; Sun L; Luo X
    Front Endocrinol (Lausanne); 2022; 13():922304. PubMed ID: 36034448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two years of replacement therapy in adults with growth hormone deficiency.
    Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Effectiveness and Comparable Safety in Biweekly
    Sun C; Lu B; Liu Y; Zhang Y; Wei H; Hu X; Hu P; Zhao Q; Liu Y; Ye K; Wang K; Gu Z; Liu Z; Ye J; Zhang H; Zhu H; Jiang Z; Liu Y; Wan N; Yan C; Yin J; Ying L; Huang F; Yin Q; Xi L; Luo F; Cheng R
    Front Endocrinol (Lausanne); 2021; 12():779365. PubMed ID: 34899612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of needle-free administration of recombinant human growth hormone in adults with growth hormone deficiency.
    Pereira AM; van der Klaauw AA; Koppeschaar HP; Smit JW; van Thiel SW; van Doorn J; Biermasz NR; Roelfsema F; Romijn JA
    Br J Clin Pharmacol; 2006 Apr; 61(4):451-5. PubMed ID: 16542206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action.
    Gilroy CA; Roberts S; Chilkoti A
    J Control Release; 2018 May; 277():154-164. PubMed ID: 29551712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between exon 3 polymorphism of growth hormone receptor gene and the responses to rhGH therapy.
    Wei Y; Zheng R; Zhou Y; Wang J; Bao P
    Int J Clin Exp Pathol; 2015; 8(6):7371-7. PubMed ID: 26261638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.